Myeloid Resistance is not Futile: Biomarkers of Immunotherapy in Bladder Cancer
Sign Up to like & getrecommendations! Published in 2021 at "Clinical Cancer Research"
DOI: 10.1158/1078-0432.ccr-21-1011
Abstract: The majority of patients with urothelial cancer do not respond to immune checkpoint blockade directed at the PD-(L)1 axis. Recently, robust profiling data were used to derive predictive biomarker signatures for both protumorigenic immunity and… read more here.
Keywords: myeloid resistance; resistance futile; immunotherapy bladder; futile biomarkers ... See more keywords